Although we have learned so much about genetics in the past few decades, there is still a lot of information we don’t know. And unfortunately, the amount of information we don’t know is greater for some groups of people than for others.
A VUS is a change in a gene that at this point in time is an unknown, meaning genetics professionals don't know if this change is harmful (i.e. disease causing) or benign. However, genetic counselors can play a critical role in helping individuals and families interpret VUS results and determine next steps for personal care.
At-home DNA tests have made a big splash about their ability to deliver medical information from the comfort of your own home. But, do these tests live up to the hype? Insight's lead genetic counselor Taya Fallen weighs in on the limitations and inaccuracies of direct-to-consumer genetic tests.
While hereditary cancer screening panels have allowed individuals to broaden the scope of testing, a lack of guidelines for moderate and low risk genes can leave some patients unsure about next steps.
Advancements in technology has created a resurgence around gene therapy which is now offering new hope for Spinal Muscular Atrophy testing.